Krebs Biochemicals (India) Buy Hold or Sell Recommendation
| KREBSBIO | 104.14 8.79 7.78% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Krebs Biochemicals and is 'Hold'. The recommendation algorithm takes into account all of Krebs Biochemicals' available fundamental, technical, and predictive indicators you will find on this site.
Check out Krebs Biochemicals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Krebs and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Krebs Biochemicals and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Krebs |
Execute Krebs Biochemicals Buy or Sell Advice
The Krebs recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Krebs Biochemicals and. Macroaxis does not own or have any residual interests in Krebs Biochemicals and or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Krebs Biochemicals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Krebs Biochemicals Trading Alerts and Improvement Suggestions
| Krebs Biochemicals had very high historical volatility over the last 90 days | |
| The company reported the revenue of 504.21 M. Net Loss for the year was (197.28 M) with profit before overhead, payroll, taxes, and interest of 244.19 M. | |
| About 78.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Krebs Biochem Standalone September 2024 Net Sales at Rs 12.86 crore, down 13.67 percent Y-o-Y - Moneycontrol |
Krebs Biochemicals Returns Distribution Density
The distribution of Krebs Biochemicals' historical returns is an attempt to chart the uncertainty of Krebs Biochemicals' future price movements. The chart of the probability distribution of Krebs Biochemicals daily returns describes the distribution of returns around its average expected value. We use Krebs Biochemicals and price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Krebs Biochemicals returns is essential to provide solid investment advice for Krebs Biochemicals.
| Mean Return | 0.43 | Value At Risk | -3.43 | Potential Upside | 5.00 | Standard Deviation | 4.44 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Krebs Biochemicals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Krebs Biochemicals Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (60.3M) | (16.0M) | (89.6M) | 136.2M | 21.5M | 20.4M | |
| Change In Cash | (171.4M) | 5.4M | (6.1M) | (148K) | 516K | 490.2K | |
| Free Cash Flow | (452.7M) | (400.8M) | (407.4M) | (355.8M) | (50.2M) | (52.7M) | |
| Depreciation | 46.8M | 51.2M | 63.0M | 65.6M | 67.7M | 48.0M | |
| Other Non Cash Items | 55.6M | 65.5M | 51.2M | 32.6M | 51.2M | 53.7M | |
| Capital Expenditures | 94.1M | 255.1M | 235.2M | 108.7M | 94.2M | 91.7M | |
| Net Income | (288.7M) | (283.6M) | (445.3M) | (246.9M) | (197.3M) | (207.1M) | |
| End Period Cash Flow | 1.7M | 7.1M | 1.0M | 858K | 1.4M | 1.3M | |
| Net Borrowings | (12.6M) | 150.7M | 334.9M | 323.8M | 372.4M | 391.0M | |
| Change To Netincome | 58.0M | 42.7M | 65.5M | 51.1M | 58.8M | 61.8M |
Krebs Biochemicals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Krebs Biochemicals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Krebs Biochemicals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Krebs stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.21 | |
β | Beta against Dow Jones | 1.67 | |
σ | Overall volatility | 4.51 | |
Ir | Information ratio | 0.07 |
Krebs Biochemicals Volatility Alert
Krebs Biochemicals and currently demonstrates below-average downside deviation. It has Information Ratio of 0.07 and Jensen Alpha of 0.21. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Krebs Biochemicals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Krebs Biochemicals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Krebs Biochemicals Fundamentals Vs Peers
Comparing Krebs Biochemicals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Krebs Biochemicals' direct or indirect competition across all of the common fundamentals between Krebs Biochemicals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Krebs Biochemicals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Krebs Biochemicals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Krebs Biochemicals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Krebs Biochemicals to competition |
| Fundamentals | Krebs Biochemicals | Peer Average |
| Return On Asset | -0.0532 | -0.14 |
| Profit Margin | (0.37) % | (1.27) % |
| Operating Margin | (0.30) % | (5.51) % |
| Current Valuation | 4.18 B | 16.62 B |
| Shares Outstanding | 21.56 M | 571.82 M |
| Shares Owned By Insiders | 77.55 % | 10.09 % |
| Price To Sales | 4.27 X | 11.42 X |
| Revenue | 504.21 M | 9.43 B |
| Gross Profit | 244.19 M | 27.38 B |
| EBITDA | (82.73 M) | 3.9 B |
| Net Income | (197.28 M) | 570.98 M |
| Cash And Equivalents | (1 K) | 2.7 B |
| Total Debt | 2.39 B | 5.32 B |
| Book Value Per Share | (55.29) X | 1.93 K |
| Cash Flow From Operations | 23.04 M | 971.22 M |
| Earnings Per Share | (10.10) X | 3.12 X |
| Number Of Employees | 191 | 18.84 K |
| Beta | 0.46 | -0.15 |
| Market Capitalization | 2.25 B | 19.03 B |
| Total Asset | 1.78 B | 29.47 B |
| Retained Earnings | (2.7 B) | 9.33 B |
| Working Capital | (443.92 M) | 1.48 B |
| Net Asset | 1.78 B |
Krebs Biochemicals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Krebs . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0968 | |||
| Daily Balance Of Power | (0.80) | |||
| Rate Of Daily Change | 0.92 | |||
| Day Median Price | 108.49 | |||
| Day Typical Price | 107.04 | |||
| Market Facilitation Index | 11.03 | |||
| Price Action Indicator | (8.74) | |||
| Period Momentum Indicator | (8.79) | |||
| Relative Strength Index | 57.89 |
About Krebs Biochemicals Buy or Sell Advice
When is the right time to buy or sell Krebs Biochemicals and? Buying financial instruments such as Krebs Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Krebs Biochemicals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Single Stock ETFs Thematic Idea Now
Single Stock ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Single Stock ETFs theme has 99 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Single Stock ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Krebs Stock
Krebs Biochemicals financial ratios help investors to determine whether Krebs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Krebs with respect to the benefits of owning Krebs Biochemicals security.